The treatment and survival of patients with postoperative recurrent thymic carcinoma and neuroendocrine carcinoma: a multicenter retrospective study.

Ryo MiyataMasatsugu HamajiMitsugu OmasaSo MiyaharaAkihiro AoyamaYutaka TakahashiRyota SumitomoCheng-Long HuangKyoko HijiyaTatsuo NakagawaYuhei YokoyamaKenzo KawakamiMakoto SonobeMasaki IkedaTakuji FujinagaMichiharu SugaShinya HirotaFumitsugu KojimaToru BandoMamoru TakahashiYasuji TeradaTsuyoshi ShojiHiromichi KatakuraYusuke MuranishiRyo MiyaharaHiroshi Date

Published in: Surgery today (2020)

Chemotherapy rather than surgery appears to be the mainstay treatment for managing patients with postoperative recurrent TC and TNEC and it may also be considered in multidisciplinary management. Further studies with a larger sample size are required to confirm our findings.

Keyphrases

patients undergoing
minimally invasive
clinical trial
combination therapy
radiation therapy
cross sectional
double blind
free survival